Selinexor in Combination with Salvage Regimen for Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Patients with TP53 Alterations

被引：1
|
作者：
Wang, Li [1 ,2 ]
Fang, Ying [1 ]
Zhang, Muchen [1 ]
Xiong, Jie [1 ]
Xu, Pengpeng [1 ]
Chen, Shu [1 ]
Zhao, Weili [1 ,2 ]
机构：
[1] Shanghai Jiao Tong Univ, Natl Res Ctr Translat Med Shanghai, Sch Med,Rui Jin Hosp, Shanghai Inst Hematol,State Key Lab Med Genom, Shanghai, Shanghai, Peoples R China
[2] Chinese French Res Ctr Living Sci & Genom, Lab Mol Pathol, Shanghai, Peoples R China
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-182674
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [11] Triple Haplotypes of the TP53 Gene in Patients with Diffuse Small B-Cell Lymphoma
    Voropaeva, E. N.
    Cherdyntseva, N. V.
    Voevoda, M. I.
    Pospelova, T. I.
    Maximov, V. N.
    Orlov, Yu. L.
    Ageeva, T. A.
    [J]. RUSSIAN JOURNAL OF GENETICS, 2019, 55 (12) : 1564 - 1568
  • [12] Molecular Subtypes and the Role of TP53 in Diffuse Large B-Cell Lymphoma and Richter Syndrome
    Negara, Ivan
    Tomuleasa, Ciprian
    Buruiana, Sanda
    Efremov, Dimitar G.
    [J]. CANCERS, 2024, 16 (12)
  • [13] Primary Gastrointestinal Diffuse Large B-cell Lymphoma Features Frequent TP53 Mutations
    Li, Huange
    Sheng, Dong
    Wang, Weige
    Xue, Tian
    Li, Xiaoqiu
    [J]. LABORATORY INVESTIGATION, 2023, 103 (03) : S592 - S593
  • [14] A drug profile on selinexor for the treatment of refractory diffuse large B-cell lymphoma
    Sylvain, Choquet
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2022, 15 (03) : 195 - 201
  • [15] Selinexor in Combination with Salvage Regimen for Refractory Peripheral T-Cell Lymphoma (PTCL) Patients
    Wang, Li
    Cai, Mingci
    Huang, Yaohui
    Xu, Pengpeng
    Chen, Shu
    Zhao, Weili
    [J]. BLOOD, 2023, 142
  • [16] Diffuse large B-cell lymphoma (DLBCL)
    Renner, C.
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2012, 82 : S10 - S10
  • [17] Clinical Impact of TP53 Gene Mutations in Diffuse Large B-Cell Lymphoma (DLBCL): An International DLBCL Rituxan-CHOP Consortium Program Study
    Young, Ken H.
    Patten, Nancy
    Truong, Sim
    Eickhoff, Jens
    Rocque, Gabrielle L.
    Malik, Jeffrey T.
    Li, Yan
    Kanehira, Kazunori
    Twohig, Matthew
    Rehrauer, William M.
    Waknitz, Michelle A.
    Kahl, Brad S.
    Moller, Michael B.
    Tzankov, Alexander
    Moreno, Santiago M.
    Piris, Miguel A.
    Visco, Carlo
    Dybkaer, Karen
    Chin, April
    Orazi, Attilio
    Chang, Jeff C.
    Bhagat, Govind
    Winter, Jane N.
    Wang, Huan-You
    Dunphy, Cherie
    O'Neill, Stacey
    Hsi, Eric D.
    Zhao, Xianfeng
    Hunt, Kristin
    Chen, Weina
    Go, Ronald S.
    Choi, William W. L.
    Zhou, Fan
    Czader, Magdalena
    Li, Yong
    Selvaggi, Suzanne
    Malter, James S.
    Wu, Lin
    [J]. BLOOD, 2009, 114 (22) : 399 - 400
  • [18] Orelabrutinib Plus R-CHOP Regimen in Treatment-Naive Patients with TP53-Mutated Diffuse Large B-Cell Lymphoma (DLBCL)
    Xiao, Yi
    Wu, Jiaying
    Zhou, Mi
    Shang, Zhen
    Zhu, Ming
    [J]. BLOOD, 2023, 142
  • [19] The Fate of Patients with Refractory Diffuse Large B Cell Lymphoma (DLBCL)
    Otahal, Pavel
    Janikova, Andrea
    Belada, David
    Prochazka, Vit
    Mocikova, Heidi
    Pirnos, Jan
    Duras, Juraj
    Kopeckova, Katerina
    Campr, Vit
    Pytlik, Robert
    Blahovcova, Petra
    Trneny, Marek
    [J]. BLOOD, 2018, 132
  • [20] Changes in non-coding sequences of the TP53 gene in diffuse large B-cell lymphoma
    Voropaeva, E. N.
    Pospelova, T., I
    Voevoda, M., I
    Maksimov, V. N.
    [J]. GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2019, 63 (03): : 239 - 249
12345